DE60010028D1 - Chlorin- und Bakteriochlorin-aminophenylDTPA Konjugate als MR Kontrastmittel und Radiopharmazeutika - Google Patents

Chlorin- und Bakteriochlorin-aminophenylDTPA Konjugate als MR Kontrastmittel und Radiopharmazeutika

Info

Publication number
DE60010028D1
DE60010028D1 DE60010028T DE60010028T DE60010028D1 DE 60010028 D1 DE60010028 D1 DE 60010028D1 DE 60010028 T DE60010028 T DE 60010028T DE 60010028 T DE60010028 T DE 60010028T DE 60010028 D1 DE60010028 D1 DE 60010028D1
Authority
DE
Germany
Prior art keywords
compounds
usually
radioactive
aminophenyldtpa
bacteriochlorin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60010028T
Other languages
English (en)
Other versions
DE60010028T2 (de
Inventor
Ravindra K Pandey
Zachary Grossman
Peter Kanter
Thomas J Dougherty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Research Inc
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of DE60010028D1 publication Critical patent/DE60010028D1/de
Application granted granted Critical
Publication of DE60010028T2 publication Critical patent/DE60010028T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
DE60010028T 1999-12-23 2000-12-20 Chlorin- und Bakteriochlorin-aminophenylDTPA Konjugate als MR Kontrastmittel und Radiopharmazeutika Expired - Lifetime DE60010028T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17196199P 1999-12-23 1999-12-23
US171961P 1999-12-23
US09/739,155 US6534040B2 (en) 1999-12-23 2000-12-18 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US739155 2000-12-18

Publications (2)

Publication Number Publication Date
DE60010028D1 true DE60010028D1 (de) 2004-05-27
DE60010028T2 DE60010028T2 (de) 2005-04-28

Family

ID=26867614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60010028T Expired - Lifetime DE60010028T2 (de) 1999-12-23 2000-12-20 Chlorin- und Bakteriochlorin-aminophenylDTPA Konjugate als MR Kontrastmittel und Radiopharmazeutika

Country Status (8)

Country Link
US (1) US6534040B2 (de)
EP (1) EP1110963B1 (de)
JP (1) JP4885354B2 (de)
AT (1) ATE264862T1 (de)
AU (1) AU779361B2 (de)
CA (1) CA2329320C (de)
DE (1) DE60010028T2 (de)
DK (1) DK1110963T3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
CA2358662A1 (en) * 1999-01-15 2000-07-20 James Chen Therapeutic compositions for metabolic bone disorders or bone metastases
JP2002534218A (ja) 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
US6454789B1 (en) 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7078014B2 (en) * 1999-12-23 2006-07-18 Health Research, Inc. Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
JP2005527493A (ja) * 2002-01-23 2005-09-15 ライト サイエンシーズ コーポレイション 光線力学療法のためのシステムおよび方法
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP2036908A3 (de) * 2002-07-02 2009-05-13 Health Research, INC. Effiziente Synthese von Pyropheophorbid-A-Derivaten
US20040010218A1 (en) * 2002-07-11 2004-01-15 Henderson Barbara W. Photodynamic therapy for the enhancement of vascular permeability to aid in drug delivery to diseased tissues
NZ541793A (en) * 2003-01-24 2008-11-28 Univ New York State Res Found Ceramic based nanoparticles for entrapping photosensitive drug/dye for photodynamic therapy
CA2589881A1 (en) * 2004-12-03 2006-06-08 University Of Utah Research Foundation Mri guided photodynamic therapy for cancer
US8236283B2 (en) 2005-01-06 2012-08-07 Ge Healthcare As Optical imaging
US20060198783A1 (en) * 2005-02-25 2006-09-07 Health Research, Inc., Roswell Park Cancer Institute Division Porphyrin-based compounds for tumor imaging and photodynamic therapy
US8198432B2 (en) * 2005-02-25 2012-06-12 Health Research, Inc. Porphyrin-based compounds for tumor imaging and photodynamic therapy
US20090169480A1 (en) * 2007-12-31 2009-07-02 Industrial Technology Research Institute Dendritic polymers and magnetic resonance imaging contrast agent employing the same
US20110070154A1 (en) * 2008-08-13 2011-03-24 Hyde Roderick A Artificial cells
US9095624B2 (en) * 2011-05-23 2015-08-04 Contango Partners Group, Inc. Modular transport platform for targeted delivery of therapeutic agents
CN104193753A (zh) * 2014-08-26 2014-12-10 江苏红豆杉药业有限公司 一种由红豆杉枝叶提取物制备光敏剂hpph的方法
CN114887055B (zh) * 2022-04-18 2023-06-16 浙江大学 一种糖靶向具有mr/nir显像和光动力治疗功能的诊疗一体化制剂及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5190966A (en) 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4968715A (en) 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5002962A (en) 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5198460A (en) 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
US5093349A (en) 1988-07-20 1992-03-03 Health Research Inc. Photosensitizing agents
US5173504A (en) 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE3922005A1 (de) * 1989-06-30 1991-01-10 Schering Ag Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
US5330741A (en) 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
US5257970A (en) 1992-04-09 1993-11-02 Health Research, Inc. In situ photodynamic therapy
US5244914A (en) 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
JPH0680671A (ja) * 1992-09-03 1994-03-22 Toyo Hatsuka Kogyo Kk ポルフィリン二量体とその用途
JPH06234661A (ja) * 1993-02-08 1994-08-23 Eiken Chem Co Ltd 動脈硬化巣のｍｒｉ造影剤およびｍｒｉ造影方法
WO1995007358A1 (en) 1993-07-30 1995-03-16 University Of Medicine & Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
US5498710A (en) 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
US5591847A (en) 1994-05-23 1997-01-07 Health Research, Inc. Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages
US5770730A (en) 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
US5952366A (en) 1996-03-08 1999-09-14 Health Research, Inc. Alkyl ether analogs of chlorins having an N-substituted imide ring
US5756541A (en) 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
ES2193581T3 (es) * 1997-10-27 2003-11-01 Res Corp Technologies Inc Agentes de resonancia magnetica nuclear para la liberacion de agentes terapeuticos.
AU752812B2 (en) * 1997-11-17 2002-10-03 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
JPH11217385A (ja) * 1998-01-30 1999-08-10 Nihon Schering Kk 含フッ素ポルフィリン錯体およびそれを含有する造影剤
US6103751A (en) 1998-06-22 2000-08-15 Health Research, Inc. Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents

Also Published As

Publication number Publication date
US20010046983A1 (en) 2001-11-29
JP4885354B2 (ja) 2012-02-29
CA2329320C (en) 2010-08-24
CA2329320A1 (en) 2001-06-23
ATE264862T1 (de) 2004-05-15
JP2001335578A (ja) 2001-12-04
EP1110963A2 (de) 2001-06-27
DK1110963T3 (da) 2004-07-05
EP1110963A3 (de) 2001-12-19
DE60010028T2 (de) 2005-04-28
AU7238400A (en) 2001-06-28
EP1110963B1 (de) 2004-04-21
AU779361B2 (en) 2005-01-20
US6534040B2 (en) 2003-03-18

Similar Documents

Publication Publication Date Title
DE60010028D1 (de) Chlorin- und Bakteriochlorin-aminophenylDTPA Konjugate als MR Kontrastmittel und Radiopharmazeutika
Jones-Wilson et al. The in vivo behavior of copper-64-labeled azamacrocyclic complexes
Viola-Villegas et al. The coordination chemistry of 1, 4, 7, 10-tetraazacyclododecane-N, N′, N ″, N′″-tetraacetic acid (H4DOTA): Structural overview and analyses on structure–stability relationships
Tircsó et al. Equilibrium and formation/dissociation kinetics of some LnIIIPCTA complexes
US8133473B2 (en) Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
DE69019584T2 (de) Makrocyclische Stickstoffliganden Verfahren zu ihrer Herstellung, ihre Metallkomplexe, sie enthaltende Diagnostische und therapeutische Mittel.
Huclier-Markai et al. Chemical and biological evaluation of scandium (III)-polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals
Chiang et al. Multifunctional ligands in medicinal inorganic chemistry-current trends and future directions
Chilla et al. Importance of DOTA derivatives in bimodal imaging
Cutler et al. Labeling and in vivo evaluation of novel copper (II) dioxotetraazamacrocyclic complexes
Price et al. Evaluation of a bispidine‐based chelator for gallium‐68 and of the porphyrin conjugate as PET/PDT theranostic agent
Sinha et al. Synthesis and properties of boron porphyrinoids
Horváth et al. Towards 213 Bi alpha-therapeutics and beyond: unravelling the foundations of efficient Bi III complexation by DOTP
Harriswangler et al. Versatile Macrocyclic Platform for the Complexation of [natY/90Y] Yttrium and Lanthanide Ions
WO1993011800A1 (en) Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
Pino-Cuevas et al. Thiosemicarbazonate complexes with affinity for amyloid-β fibers: synthesis, characterization and biological studies
Dai et al. Design of functional chiral cyclen-based radiometal chelators for theranostics
Hernández-Gil et al. Development and Validation of Nerve-Targeted Bacteriochlorin Sensors
US7078014B2 (en) Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
Mirica et al. Neutral Metal-Chelating Compounds with High 64Cu Affinity for PET Imaging Applications in Alzheimer’s Disease
ES2354666B1 (es) Compuesto para la extraccion selectiva de estroncio (ii) y plomo (ii).
Martin Chelation of Luminescent and Radioactive Lanthanides for Targeted In Vivo Bioimaging
Smith Cherenkov Radiation-Mediated Excitation of Luminescent Terbium Coordination Complexes
Yu et al. Coordination Chemistry of Sulfur-Containing Bifunctional Chelators: Toward in Vivo Stabilization of 64Cu PET Imaging Agents for Alzheimer’s Disease
Lambidis Synthesis and photophysical studies of metal complexes for biological applications

Legal Events

Date Code Title Description
8364 No opposition during term of opposition